Mangalam Drugs & Organics Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 2/6
Mangalam Drugs & Organics has a total shareholder equity of ₹1.4B and total debt of ₹1.1B, which brings its debt-to-equity ratio to 78.8%. Its total assets and total liabilities are ₹3.3B and ₹2.0B respectively. Mangalam Drugs & Organics's EBIT is ₹139.5M making its interest coverage ratio 1. It has cash and short-term investments of ₹9.1M.
Anahtar bilgiler
78.8%
Borç/özkaynak oranı
₹1.07b
Borç
| Faiz karşılama oranı | 1x |
| Nakit | ₹9.11m |
| Eşitlik | ₹1.36b |
| Toplam yükümlülükler | ₹1.98b |
| Toplam varlıklar | ₹3.34b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 532637's short term assets (₹1.8B) exceed its short term liabilities (₹1.6B).
Uzun Vadeli Yükümlülükler: 532637's short term assets (₹1.8B) exceed its long term liabilities (₹338.5M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 532637's net debt to equity ratio (78.1%) is considered high.
Borcun Azaltılması: 532637's debt to equity ratio has increased from 65.7% to 78.8% over the past 5 years.
Borç Kapsamı: 532637's debt is not well covered by operating cash flow (3.7%).
Faiz Kapsamı: 532637's interest payments on its debt are not well covered by EBIT (1x coverage).